[1] Soelberg KK, Bonnema SJ, Brix TH, et al. Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography: a systematic review[J]. Thyroid, 2012, 22(9):918-925. DOI:10.1089/thy.2012.0005.
[2] Bae JS, Chae BJ, Park WC, et al. Incidental thyroid lesions detected by FDG-PET/CT:prevalence and risk of thyroid cancer[J]. World J Surg Oncol, 2009, 7:63. DOI:10.1186/1477-7819-7-63.
[3] Pampaloni MH, Win AZ. Prevalence and Characteristics of Incidentalomas Discovered by Whole Body FDG PETCT[J]. Int J Mol Imaging, 2012, 2012:476763. DOI:10.1155/2012/476763.
[4] Nakamoto Y, Tatsumi M, Hammoud D, et al. Normal FDG distribution patterns in the head and neck:PET/CT evaluation[J]. Radiology, 2005, 234(3):879-885. DOI:10.1148/radiol.2343030301.
[5] Han YM, Kim YC, Park EK, et al. Diagnostic value of CT density in patients with diffusely increased FDG uptake in the thyroid gland on PET/CT images[J]. AJR Am J Roentgenol, 2010, 195(1):223-228. DOI:10.2214/AJR.09.3319.
[6] Soelberg KK, Bonnema SJ, Brix TH, et al. Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography:a systematic review[J]. Thyroid, 2012, 22(9):918-925. DOI:10.1089/thy.2012.0005.
[7] Chun AR, Jo HM, Lee SH, et al. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography[J]. Endocrinol Metab (Seoul), 2015, 30(1):71-77. DOI:10.3803/EnM.2015.30.1.71.
[8] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132. DOI:10.3322/caac.21338.
[9] Czepczyński R, Stangierski A, Oleksa R, et al. Incidental 18F-FDG uptake in the thyroid in patients diagnosed with PET/CT for other malignancies[J]. Nucl Med Rev Cent East Eur, 2011, 14(2):68-72. DOI:10.5603/NMR.2011.00018.
[10] Barrio M, Czernin J, Yeh MW, et al. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions:an 18F-FDG PET/CT study in more than 6000 patients[J]. Nucl Med Commun, 2016, 37(12):1290-1296. DOI:10.1097/MNM.0000000000000592.
[11]

Pattison DA, Bozin M, Gorelik A, et al. 18F-fluorodeoxyglycose-avid thyroid incidentalomas: the importance of contextual interpretation[J/OL]. J Nucl Med, 2017[2017-10-24]. http://jnm.snmjournals.org/content/early/2017/10/11/jnumed.117.198085. DOI:10.2967/jnumed.117.198085.

[12] Hagenimana N, Dallaire J, Vallée É, et al. Thyroid incidentalomas on 18FDG-PET/CT: a metabolico-pathological correlation[J]. J Otolaryngol Head Neck Surg, 2017, 46(1):22. DOI:10.1186/s40463-017-0200-8.
[13] Lee WM, Kim BJ, Kim MH, et al. Characteristics of thyroid incidentalomas detected by pre-treatment 18F-FDG PET or PET/CT in patients with cervical cancer[J]. J Gynecol Oncol, 2012, 23(1):43-47. DOI:10.3802/jgo.2012.23.1.43.
[14] Chen YK, Ding HJ, Chen KT, et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects[J]. Anticancer Res, 2005, 25(2B):1421-1426.
[15] Sharma SD, Jacques T, Smith S, et al. Diagnosis of incidental thyroid nodules on 18F-fluorodeoxyglucose positron emission tomography imaging: are these significant?[J]. J Laryngol Otol, 2015, 129(1):53-56. DOI:10.1017/S0022215114003107.
[16] Ho TY, Liou MJ, Lin KJ, et al. Prevalence and significance of thyroid uptake detected by 18F-FDG PET[J]. Endocrine, 2011, 40(2):297-302. DOI:10.1007/s12020-011-9470-5.
[17] Choi JY, Lee KS, Kim HJ, et al. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT:clinical significance and improved characterization[J]. J Nucl Med, 2006, 47(4):609-615.
[18] Agrawal K, Weaver J, Ngu R, et al. Clinical significance of patterns of incidental thyroid uptake at 18F-FDG PET/CT[J]. Clin Radiol, 2015, 70(5):536-543. DOI:10.1016/j.crad.2014.12.020.
[19] 李雪娜, 尹雅芙, 杜补林, 等. 18F-FDG PET/CT显像偶发甲状腺癌的葡萄糖代谢与临床病理学的相关性研究[J].中国癌症杂志, 2016, 26(6):527-532. DOI:10.19401/j.cnki.1007-3639. 2016. 06. 008.
Li XN, Yin YF, Du BL, et al.The correlation study between the glucose metabolism of 18F-FDG PET/CT incidental thyroid cancer and clinicopathologic characteristics[J]. Chin Oncol, 2016, 26(6):527-532.  doi: 10.19401/j.cnki.1007-3639.2016.06.008
[20] Demir Ö, Köse N, Özkan E, et al. Clinical significance of thyroid incidentalomas identified by 18F-FDG PET/CT: correlation of ultrasonograpy findings with cytology results[J]. Nucl Med Commun, 2016, 37(7):715-720. DOI:10.1097/MNM.0000000000000495.
[21] Kang KW, Kim SK, Kang HS, et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects[J]. J Clin Endocrinol Metab, 2003, 88(9):4100-4104. DOI:10.1210/jc.2003-030465.
[22] Bonabi S, Schmidt F, Broglie MA, et al. Thyroid incidentalomas in FDG-PET/CT: prevalence and clinical impact[J]. Eur Arch Otorhinolaryngol, 2012, 269(12):2555-2560. DOI:10.1007/s00405-012-1941-7.
[23] Mirza AA, Pai E, Srinivas KG, et al. Diagnostic Dilemma in a Thyroid Incidentaloma: Second Primary versus Metastatic Nodule?[J]. J Clin Diagn Res, 2016, 10(6):PD10-12. DOI:10.7860/JCDR/2016/18279.8011.
[24] 王佩国, 王平.甲状腺转移癌(附9例报告)[J].中国肿瘤临床, 2005, 32(13):775-776. DOI:10.3969/j.issn.1000-8179. 2005.13. 016.
Wang PG, Wang P. Metaset carcinoma of the thyroids[J]. Chin J Clin Oncol, 2005, 32(13):775-776.  doi: 10.3969/j.issn.1000-8179.2005.13.016
[25] Osawa M, Takigawa N, Kiura K, et al. Isolated metastasis of lung cancer to the thyroid gland[J]. Lung Cancer, 2007, 58(1):156-158. DOI:10.1016/j.lungcan.2007.04.014.
[26] Lam KY, Lo CY. Metastatic tumors of the thyroid gland:a study of 79 cases in Chinese patients[J]. Arch Pathol Lab Med, 1998, 122(1):37-41.
[27] Thuillier P, Roudaut N, Crouzeix G, et al. Malignancy rate of focal thyroid incidentaloma detected by FDG PET-CT: results of a prospective cohort study[J]. Endocr Connect, 2017, 6(6):413-421. DOI:10.1530/EC-17-0099.
[28] Targe M, Basu S. Focal thyroid incidentaloma on whole body fluorodeoxyglucose positron emission tomography/computed tomography in known cancer patients:A case-based discussion with a series of three examples[J]. J Cancer Res Ther, 2015, 11(4):1029. DOI:10.4103/0973-1482.154029.
[29] 吴江, 朱虹, 王新刚, 等. 18F-FDG PET/CT显像在甲状腺病变的应用:与病理对比分析[J].中国临床医学影像杂志, 2013, 24(4):242-246. DOI:10.3969/j.issn.1008-1062.2013.04.006.
Wu J, Zhu H, Wang XG, et al. Application of 18F-FDG PET/CT in thyroid disease and correlative with histopathological results[J]. J Chin Clin Med Imaging, 2013, 24(4):242-246.  doi: 10.3969/j.issn.1008-1062.2013.04.006
[30] Agrawal K, Weaver J, Ul-Hassan F, et al. Incidence and Significance of Incidental Focal Thyroid Uptake on 18F-FDG PET Study in a Large Patient Cohort: Retrospective Single-Centre Experience in the United Kingdom[J]. Eur Thyroid J, 2015, 4(2):115-122. DOI:10.1159/000431319.
[31] Qu N, Zhang L, Lu ZW, et al. Risk of malignancy in focal thyroid lesions identified by 18F-fluorodeoxyglucose positron emission tomography or positron emission tomography/computed tomography:evidence from a large series of studies[J]. Tumour Biol, 2014, 35(6):6139-6147. DOI:10.1007/s13277-014-1813-4.
[32] Bertagna F, Treglia G, Piccardo A, et al. Diagnostic and clinical significance of 18F-FDG-PET/CT thyroid incidentalomas[J]. J Clin Endocrinol Metab, 2012, 97(11):3866-3875. DOI:10.1210/jc.2012-2390.
[33]

Pattison DA, Bozin M, Gorelik A, et al. 18F-fluorodeoxyglycose-avid thyroid incidentalomas: the importance of contextual interpretation[J/OL]. J Nucl Med, 2017[2017-10-23]. http://jnm.snmjournals.org/content/early/2017/10/11/jnumed.117.198085. DOI:10.2967/jnumed.117.198085.

[34] Makis W, Ciarallo A. Thyroid Incidentalomas on 18F-FDG PET/CT:Clinical Significance and Controversies[J]. Mol Imaging Radionucl Ther, 2017, 26(3):93-100. DOI:10.4274/mirt.94695.
[35] Hagenimana N, Dallaire J, Vallée É, et al. Thyroid incidentalomas on 18FDG-PET/CT: a metabolico-pathological correlation[J]. J Otolaryngol Head Neck Surg, 2017, 46(1):22. DOI:10.1186/s40463-017-0200-8.
[36] Yaylali O, Kirac FS, Yuksel D, et al. Evaluation of focal thyroid lesions incidentally detected in fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography images[J]. Indian J Cancer, 2014, 51(3):236-240. DOI:10.4103/0019-509X.146737.
[37] Lee S, Park T, Park S, et al. The Clinical Role of Dual-Time-Point 18F-FDG PET/CT in Differential Diagnosis of the Thyroid Incidentaloma[J]. Nucl Med Mol Imaging, 2014, 48(2):121-129. DOI:10.1007/s13139-013-0247-z.
[38] D'Souza MM, Marwaha RK, Sharma R, et al. Prospective evaluation of solitary thyroid nodule on 18F-FDG PET/CT and high-resolution ultrasonography[J]. Ann Nucl Med, 2010, 24(5):345-355. DOI:10.1007/s12149-010-0357-y.
[39] Kim SJ, Kim BH, Jeon YK, et al. Limited diagnostic and predictive values of dual-time-point 18F FDG PET/CT for differentiation of incidentally detected thyroid nodules[J]. Ann Nucl Med, 2011, 25(5):347-353. DOI:10.1007/s12149-011-0468-0.
[40] Hsiao YC, Wu PS, Chiu NT, et al. The use of dual-phase 18F-FDG PET in characterizing thyroid incidentalomas[J]. Clin Radiol, 2011, 66(12):1197-1202. DOI:10.1016/j.crad.2011.08.005.
[41] 陈聪霞, 李文婵, 刘甫庚, 等.腺癌性孤立性肺结节的18F-FDG PET/CT表现[J].中华核医学与分子影像杂志, 2011, 31(6):382-385. DOI:10.3760/cma.j.issn.0253-9780.2011.06.008.
Chen CX, Li WC, Liu PG, et al. The features of solitary pulmonary nodules of adenocarcinoma on 18F-FDG PET/CT[J]. Chin J Nucl Med Mol Imaging, 2011, 31(6):382-385.  doi: 10.3760/cma.j.issn.0253-9780.2011.06.008
[42] 沈伟明, 张黄华, 倪耿欢.多层螺旋CT对甲状腺良恶性肿瘤的诊断及鉴别诊断价值[J].医学影像学杂志, 2015, 25(9):1690-1692.
Shen WM, Zhang HH, Ni GH. The value of MSCT in diagnosis and differential diagnosis of benign and malignant thyroid tumors[J]. J Med Imaging, 2015, 25(9):1690-1692.
[43] Bakhshayesh KM, Doroudinia A, Joukar F, et al. Hypermetabolic Thyroid Incidentaloma on Positron Emission Tomography:Review of Laboratory, Radiologic, and Pathologic Characteristics[J/OL]. J Thyroid Res, 2017, 2017:7176934[2017-10-24]. https://www.hindawi.com/journals/jtr/2017/7176934. DOI:10.1155/2017/7176934.
[44] 关志伟, 徐白萱, 陈英茂, 等.大规模人群FDG PET/CT意外发现甲状腺高代谢结节的回顾性分析[J].中华核医学与分子影像杂志, 2012, 32(1):32-35. DOI:10.3760/cma.j.issn.2095-2848. 2012.01.010.
Guan ZW, Xu BX, Chen YM, et al. Retrospective evaluation of focal hypermetabolic thyroid nodules incidentally identified by 18F-FDG PET/CT in a large population[J]. Chin J Nucl Med Mol Imaging, 2012, 32(1):32-35.  doi: 10.3760/cma.j.issn.2095-2848.2012.01.010
[45] 马春旭, 袁卫红.甲状腺结节影像学诊断研究进展[J].国际放射医学核医学杂志, 2014, 38(1):48-52. DOI:10.3760/cma.j.issn1673-4114.2014.01.010.
Ma CX, Yuan WH. Advanced research on imaging diagnosis of thyroid nodule[J]. Int J Radiat Med Nucl Med, 2014, 38(1):48-52.  doi: 10.3760/cma.j.issn1673-4114.2014.01.010
[46] 韩志江, 项晶晶, 包凌云, 等.甲状腺钙化性病变的超声和CT联合诊断[J].国际放射医学核医学杂志, 2016, 39(4):416-421. DOI:10.19300/j.2016.J4246.
Han ZJ, Xiang JJ, Bao LY, et al. Combined ultrasound and CT in diagnosis of thyroid calcified lesions[J]. Int J Radiat Med Nucl Med, 2016, 39(4):416-421.  doi: 10.19300/j.2016.J4246
[47] 朱林波, 王淑侠, 徐卫平, 等. 18F-氟代脱氧葡萄糖正电子成像术/计算机断层扫描对甲状腺结节鉴别诊断的价值[J].中华诊断学电子杂志, 2014, 2(4):249-251. DOI:10. 3877/cma.j.issn.2095655X. 2014. 04. 002.
Zhu LB, Wang SX, Xu WP, et al. Diagnostic vaule of 18F-FDG PET/CT in the differential diagnosis of thyroid nodules[J]. Chin J Diagnostics (Electronic Edition), 2014, 2(4):249-251.  doi: 10.3877/cma.j.issn.2095655X.2014.04.002
[48] Kim TH, Ji YB, Song CM, et al. SUVmax of 18F-FDG PET/CT in the differential diagnosis of benign and malignant thyroid nodules according to tumor volume[J]. World J Surg Oncol, 2015, 13:217. DOI:10.1186/s12957-015-0635-1.
[49] 郑冬, 牛力璇, 田嘉禾, 等. 18F-FDG PET/CT最大标准化摄取值与舌鳞状细胞癌临床特征的关系[J].中国医学影像学杂志, 2017, 25(7):481-486. DOI:10.3969/j.issn.1005-5185.2017.07.001.
Zheng D, Niu LX, Tian JH, et al. Relationship between maximum standardized uptake value of 18F-FDG PET/CT and clinical features of tongue squamous cell carcinoma[J]. Chin J Med Imaging, 2017, 25(7):481-486.  doi: 10.3969/j.issn.1005-5185.2017.07.001
[50] Brindle R, Mullan D, Yap BK, et al. Thyroid incidentalomas discovered on positron emission tomography CT scanning-Malignancy rate and significance of standardised uptake values[J]. Eur J Surg Oncol, 2014, 40(11):1528-1532. DOI:10.1016/j.ejso.2014.05.005.
[51] Rothman IN, Middleton L, Stack BC, et al. Incidence of diffuse FDG uptake in the thyroid of patients with hypothyroidism[J]. Eur Arch Otorhinolaryngol, 2011, 268(10):1501-1504. DOI:10.1007/s00405-011-1512-3.
[52] Kurata S, Ishibashi M, Hiromatsu Y, et al. Diffuse and diffuse-plus-focal uptake in the thyroid gland identified by using FDG-PET:prevalence of thyroid cancer and Hashimoto's thyroiditis[J]. Ann Nucl Med, 2007, 21(6):325-330. DOI:10.1007/s12149-007-0030-2.
[53] Yang Z, Shi W, Zhu B, et al. Prevalence and risk of cancer of thyroid incidentaloma identified by fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography[J]. J Otolaryngol Head Neck Surg, 2012, 41(5):327-333.
[54] Resende de Paiva C, Grønhøj C, Feldt-Rasmussen U, et al. Association between Hashimoto's Thyroiditis and Thyroid Cancer in 64, 628 Patients[J]. Front Oncol, 2017, 7:53. DOI:10.3389/fonc.2017.00053.
[55] Avgoustou C, Avgoustou E. Coexistence of Hashimoto's thyroiditis and papillary thyroid carcinoma[J]. Hellenic J Surg, 2017, 89(2):73-78. DOI:10.1007/s13126-017-0387-1.
[56] Lai X, Xia Y, Zhang B, et al. A meta-analysis of Hashimoto's thyroiditis and papillary thyroid carcinoma risk[J]. Oncotarget, 2017, 8(37):62414-62424. DOI:10.18632/oncotarget.18620.